LD 1619
pg. 7
Page 6 of 11 An Act to Create a Patients' Bill of Rights Page 8 of 11
Download Bill Text
LR 251
Item 1

 
provided under the health plan, the carrier shall make or provide
for a referral to a specialist who is available and accessible to
provide the treatment for such condition or disease in accordance
with the following provisions.

 
A.__A carrier may require that the care provided to an
enrollee as a result of a referral under this subsection be
pursuant to a treatment plan developed by the specialist and
approved by the carrier in consultation with the enrollee
and the enrollee's primary care physician in accordance with
applicable quality assurance and utilization review
standards of the carrier.

 
B.__A carrier is not required to provide a referral to a
specialist that is not a participating provider unless the
carrier does not have an appropriate specialist that is
available and accessible to treat the enrollee's condition.

 
C.__If a carrier refers an enrollee to a nonparticipating
specialist, the specialist must provide the services
pursuant to the treatment plan at no additional cost to the
enrollee beyond what the enrollee would otherwise pay for
services rendered by such a specialist that is a
participating provider.

 
5.__Standing referrals to specialists. A carrier shall have a
procedure to allow enrollees who have a condition that requires
ongoing care from a specialist to receive a standing referral to
such a specialist for treatment of the condition.__If the
carrier, or the enrollee's primary care physician, in
consultation with the carrier's medical director, determines that
a standing referral is appropriate, the carrier shall make a
referral to a specialist.

 
§4312.__Access to clinical trials

 
1.__Qualified individual.__An enrollee is eligible for
coverage for participation in an approved clinical trial if the
enrollee meets the following conditions:

 
A.__The enrollee has a life-threatening or serious illness
for which no standard treatment is effective;

 
B.__The enrollee is eligible to participate according to the
clinical trial protocol with respect to treatment of such an
illness;

 
C.__The enrollee's participation in the trial offers
meaningful potential for a significant clinical benefit to
the enrollee; and


Page 6 of 11 Top of Page Page 8 of 11